Fig. 1. (A) Cumulative survival curves for recurrence according to metastatic axillary lymph node ratio (mALNR). The 10-year survival rate was different between the Low65 group (mALNR ≤ 0.65; 57.0%) and the High65 group (mALNR > 0.65; 35.0%), P < 0.001. (B) Cumulative survival curves for mortality according to metastatic axillary lymph node ratio. The 10-year survival rate was different between the Low65 group (64.2%) and the High65 group (38.3%), P < 0.001. Low65, patients with mALNR ≤ 0.65; High65, patients with mALNR > 0.65.